Torres S Edward

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Torres S Edward
CIK #0001552293
EDGAR Form CIK 2011 - 2026
3 [0001552293]
4 [0001552293]
Form 3/4/5 Subject 2011 - 2026
Surface Oncology Inc
LV Management Group LLC
Hall Steven Edward
Torres S Edward
Lilly Ventures Fund I LLC
Rein Therapeutics Inc
Protagonist Therapeutics Inc
Shanafelt Armen
Spyre Therapeutics Inc
Globeimmune Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Surface Oncology Inc SURF
Series A Preferred Stock · derivative
2018-04-23 Conversion 7,000,000
Surface Oncology Inc SURF
Common Stock
2018-04-23 Conversion 3,181,817
Surface Oncology Inc SURF
Common Stock
2018-04-23 Buy 266,000 $15.00 3,990,000
Rein Therapeutics Inc ALRN
Common Stock
2017-07-05 Buy 250,000 $15.00 3,750,000
Rein Therapeutics Inc ALRN
Series D Preferred Stock · derivative
2017-07-05 Conversion 3,390,885 $0.00
Rein Therapeutics Inc ALRN
Series F Preferred Stock · derivative
2017-07-05 Conversion 1,443,972 $0.00
Rein Therapeutics Inc ALRN
Series E-2 Preferred Stock · derivative
2017-07-05 Conversion 1,907,373 $0.00
Rein Therapeutics Inc ALRN
Series E-3 Preferred Stock · derivative
2017-07-05 Conversion 1,654,411 $0.00
Rein Therapeutics Inc ALRN
Common Stock
2017-07-05 Conversion 844,987
Protagonist Therapeutics Inc PTGX
Common Stock
2016-08-16 Conversion 678,712
Protagonist Therapeutics Inc PTGX
Series B Preferred Stock · derivative
2016-08-16 Conversion 9,142,857 $0.00
Protagonist Therapeutics Inc PTGX
Series C Preferred Stock · derivative
2016-08-16 Conversion 9,841,333 $0.00
Protagonist Therapeutics Inc PTGX
Common Stock
2016-08-16 Conversion 630,541
Protagonist Therapeutics Inc PTGX
Common Stock
2016-08-16 Conversion 206,896
Protagonist Therapeutics Inc PTGX
Common Stock
2016-08-16 Buy 583,333 $12.00 6,999,996
Protagonist Therapeutics Inc PTGX
Series A Preferred Stock · derivative
2016-08-16 Conversion 3,000,000 $0.00
Globeimmune Inc GBIM
Common Stock
2016-03-17 Sell 26,188 $1.67 43,734
Receptos Inc RCPT
Stock Option (right to buy) · derivative
2015-08-27 Disposed to issuer 9,400 $204.56 1,922,864
Receptos Inc RCPT
Stock Option (right to buy) · derivative
2015-08-27 Disposed to issuer 18,800 $213.23 4,008,724
Receptos Inc RCPT
Common Stock
2015-08-27 Disposed to issuer 7,400
showing 20 of 55 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com